No drugs are specifically indicated for MASLD, but the FDA has granted accelerated approval to two drugs for non-cirrhotic ...

The number of adults living with chronic kidney disease has more than doubled since 1990 to reach nearly 800 million people ...

Are you ready for this? Health insurers have announced that the monthly premiums for medical coverage will rise anywhere ...

The Trump administration has directed visa officers to consider obesity and other chronic health conditions when deciding ...

Visa checkup: The State Department is now considering chronic conditions such as obesity, diabetes and heart disease when ...

Black and Hispanic individuals with obesity appear underrepresented in GLP-1 weight loss trials, compared with the overall ...

As schools grapple with the new framework, female athletes say the benefits largely favor football and men’s basketball ...

Doctors at New York University say two new studies show that they are a significant step closer to making cross-species kidney transplants a real option in the near future.

BioArctic AB's (publ) partner Eisai announced today that Leqembi (lecanemab) has been approved for once every four weeks intravenous (IV) maintenance dosing for the treatment of early Alzheimer's ...